GMED
Globus Medical
73.80$
-3.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +107.3% | -50.0% | +3.6% | +275.3% | +3.3% | -15.7% | -56.1% | +220.7% | -0.4% | -18.6% | +3.6% | – | |
| – | +90.3% | -22.3% | +15.1% | +5.3% | +1.9% | -3.2% | +6.9% | +0.7% | -1.1% | -0.7% | -0.5% | – | |
| – | -45.3% | +38.7% | -25.8% | -4.7% | -2.5% | +10.9% | +3.1% | -15.3% | -1.0% | +10.5% | +6.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -21.8% | -64.8% | -689.8% | – | -2,249.7% | – | – | – | |
| – | +6.3% | +24.9% | -2.7% | +50.9% | -59.2% | +140.2% | +25.4% | -40.2% | +82.4% | -29.5% | -16.3% | – | |
| – | – | -114.5% | -77.7% | +44.2% | +595.7% | – | -327.7% | -74.6% | +46.9% | +63.9% | -29.4% | – | |
| – | – | -63.1% | -98.2% | -100.0% | – | +18,945.1% | -86.9% | +60.0% | +12.5% | -100.0% | – | – | |
| – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | |
| – | -16,750.5% | -51.2% | – | +124.9% | +205.0% | -1,163.7% | -96.1% | +28.5% | – | +37.7% | -839.1% | – | |
| – | – | -160.3% | – | +276.7% | -23.9% | -299.9% | – | – | +8.5% | -77.5% | -252.9% | – | |
| – | +182.5% | -70.9% | +11.1% | +511.1% | +19.5% | -29.5% | -80.7% | +732.1% | -12.1% | -15.4% | +8.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.